期刊文献+

NO-1886对高糖高脂饲料喂养新西兰兔糖代谢的影响(英文) 被引量:6

NO-1886 improves glucose metabolism in high fat/ high sucrose-fed New Zealand white rabbits
暂未订购
导出
摘要 合成药NO - 1886是脂蛋白脂肪酶 (LPL)的激动剂 ,能降低血浆甘油三酯 (TG)并升高高密度脂蛋白胆固醇 (HDL -c)水平。我们曾发现NO - 1886还具有降低血糖的作用。本研究主要观察NO - 1886对糖尿病兔胰岛素抵抗及 β -细胞功能方面的影响。用高糖高脂饲料诱导 ,使新西兰兔血浆葡萄糖升高 ,发生胰岛素抵抗。在高糖高脂饲料中添加 1%NO - 1886进行治疗。结果发现NO - 1886可抑制血清葡萄糖升高 ,经糖耐量和胰岛素敏感性试验检测 ,NO - 1886可保护胰岛素的急性相分泌 ,增强胰岛素对葡萄糖的清除能力。研究结果提示NO - 1886具有改善胰岛素抵抗、降低血糖的作用。 Synthetic compound NO-1886 is a lipoprotein lipase activator which lowers plasma triglycerides and elevates high-density lipoprotein cholesterol(HDL-C). Recently, we found that NO-1886 also had an action of reducing plasma glucose in high fat/high sucrose diet induced diabetic rabbit. In the current study, we investigated the effects of NO-1886 on insulin resistance and B-cell function in the rabbits. Our results showed that high fat/high sucrose feeding increased plasma glucose levels . This diet also induced insulin resistance, impairment of acute insulin response to glucose loading. Supplementing 1% NO-1886 into the high fat/high sucrose diet resulted in decreased serum glucose levels. We also found a clear increased glucose clearance and a protected acute insulin response to intravenous glucose load by NO-1886 supplementation. These data suggest that NO-1886 suppresses the elevation of blood glucose in rabbits induced by feeding a high fat/high sucrose diet probably through improving insulin resistance.
出处 《中国现代医学杂志》 CAS CSCD 2003年第22期37-41,共5页 China Journal of Modern Medicine
关键词 NO-1886 新西兰兔 胰岛素抵抗 糖尿病 NO-1886 CAS 133208-93-2 Glucose Triglycerides Free fatty acids Insulin resistance Diabetes Rabbits
  • 相关文献

参考文献12

  • 1[1]Sivitz WI. Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression[J]. Postgrad Med,2001 ,109:55-59.
  • 2[2]Groop L. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion[J]. Int J Clin Pract Suppl,2000,(113):3-13.
  • 3[3]Leibowitz G, Yuli M, Donath MY, et al. Beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes[J]. Diabetes,2001, 50 Suppl 1:S113-S117.
  • 4[4]Thresher JS, Podolin DA, Wei Y,et al.Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance[J]. Am J Physiol Regul Integr Comp Physiol,2000,279:1334-1340.
  • 5[5]Weidong Yin, Zhonghua Yuan, Baotang Yang. A diet high in saturated fat and sucrose alters glucoregulation, and induces aortic fatty streaks in New Zealand White rabbits[J]. Int J Experimental Diabetes Research, 2002,3(3): 179-184.
  • 6[6]Kusunoki M, Hara T, Tsutsumi K, et al. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet[J]. Diabetologia, 2000,43:875-880.
  • 7[7]Tsutsumi K, Inoue Y, Shima A, et al. Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats[J]. Diabetes, 1995,44:414-417.
  • 8[8]Tsutsumi K, Inoue Y, Murase T. Effects of NO-1886, a lipoprotein lipase promoting agent on homozygous and heterozygous WHHL rabbits[J]. Arzneim Forsch, 2000,50:118-121.
  • 9[9]Hara T, Cameron-Smith D, Cooney GJ, et al. The action of novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats[J]. Metabolism, 1998,47:149-153.
  • 10[10]Ginsberg HN. Diabetic dyslipidemia basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels[J].Diabetes, 1996,45 suppl 3:s27-30

同被引文献101

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部